PT-141 (Bremelanotide) 10mg – 50 Vials | 30% Off Bulk

Product Overview

PT-141, also known by its INN designation Bremelanotide, is a cyclic melanocortin receptor-targeting peptide that has attracted significant academic and preclinical research interest worldwide. Revo Peptide offers this compound in a premium bulk configuration—50 individually sealed vials, each containing 10mg of lyophilized peptide—at a 30% bulk discount, delivering exceptional cost efficiency for research institutions, university laboratories, and licensed procurement teams requiring consistent, large-quantity supply. This product is manufactured under stringent quality protocols and is intended exclusively for in vitro and laboratory research applications.

Peptide Structure & Amino Acid Sequence

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH). Its confirmed amino acid sequence is:

• Sequence: Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-OH

The cyclic architecture, formed via a lactam bridge between the aspartate and lysine residues, confers enhanced conformational rigidity and metabolic stability compared to linear melanocortin analogues. The incorporation of D-Phe at position 7 further increases resistance to enzymatic degradation, making it a structurally robust subject for receptor-binding and pharmacodynamic research models.

Chemical & Physical Characteristics

• Molecular Formula: C₅₀H₆₈N₁₄O₁₀
• Molecular Weight: 1,025.16 g/mol
• Appearance: White to off-white lyophilized powder
• Solubility: Soluble in sterile water or 1% acetic acid solution
• Storage Stability: Stable under recommended cold-chain conditions

The peptide’s solubility profile in aqueous and mildly acidic media makes it well-suited for standard laboratory reconstitution workflows used in in vitro assay preparation.

Purity & Analytical Verification (HPLC & MS)

Every production batch of PT-141 (Bremelanotide) supplied by Revo Peptide undergoes dual-method analytical verification prior to release. Reversed-phase High-Performance Liquid Chromatography (RP-HPLC) confirms peptide purity at ≥99%, while mass spectrometry (MS) validates the exact molecular mass and confirms structural identity. Certificates of Analysis (CoA) reflecting these results are available upon request, ensuring full analytical traceability for research documentation and institutional compliance requirements.

Quality Control & Lyophilization Integrity

Revo Peptide applies pharmaceutical-grade lyophilization (freeze-drying) techniques to all peptide vials. The lyophilization process removes residual moisture to levels that maximize long-term stability and prevent degradation during storage and transit. Each vial is individually sealed under inert atmosphere conditions, and the lyophilized cake is visually inspected for uniformity and integrity before dispatch. Batch-level quality control records are maintained to support reproducible research outcomes across all vials within a given lot.

Safety, Handling & Laboratory Precautions

PT-141 (Bremelanotide) is supplied exclusively for qualified laboratory use by trained researchers. Standard laboratory personal protective equipment (PPE)—including nitrile gloves, safety eyewear, and appropriate lab coat—should be worn when handling lyophilized peptide material. Avoid inhalation of powder during weighing or transfer operations. All handling should comply with institutional biosafety protocols and applicable local regulations governing research chemicals. This compound is not approved for any form of human or animal administration.

Reconstitution, Packaging & Storage

For laboratory reconstitution purposes, sterile water or a 1% acetic acid solution is recommended as the diluent to achieve a clear, homogeneous solution suitable for in vitro research use. Each vial should be reconstituted gently to avoid foaming or peptide degradation. Revo Peptide recommends the following storage conditions:

• Long-term storage: −20°C (lyophilized, sealed vials)
• Short-term working stock: 2–8°C (post-reconstitution, use promptly)
• Avoid: Repeated freeze-thaw cycles and prolonged exposure to light or humidity

Bulk orders are shipped with appropriate cold-pack insulation to maintain product integrity throughout transit.

Intended Research Use & Market Positioning

PT-141 (Bremelanotide) is an established subject of academic research in the fields of melanocortin receptor pharmacology, neuropeptide signaling, and central nervous system receptor biology. It is widely referenced in peer-reviewed literature examining MC3R and MC4R receptor interactions. Revo Peptide positions this 50-vial bulk offering as the optimal procurement solution for research teams requiring sustained, high-volume access to a consistently pure and analytically verified melanocortin peptide. The 30% bulk discount structure is designed to support grant-funded projects, multi-phase studies, and institutional purchasing programs.

Ordering, Availability & Fulfillment

This PT-141 (Bremelanotide) 10mg 50-vial bulk pack is available to order now directly through Revo Peptide’s secure online store. Orders are processed promptly, with cold-chain compliant packaging applied to all peptide shipments. Revo Peptide maintains consistent inventory levels to support uninterrupted research supply. For wholesale inquiries, institutional purchase orders, or volume pricing beyond this listing, contact our team directly. Buy online today and take advantage of the best price available for bulk Bremelanotide research peptide.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. PT-141 (Bremelanotide) is sold by Revo Peptide strictly as a laboratory research reagent. It is the sole responsibility of the purchasing researcher or institution to ensure compliance with all applicable local, national, and international laws and regulations governing the procurement, storage, and use of research peptides. Revo Peptide makes no claims regarding therapeutic efficacy, safety for administration, or suitability for any use beyond qualified in vitro laboratory research.